successful shortening of tuberculosis treatment using adjuvant host-directed therapy with fda-approved phosphodiesterase inhibitors in the mouse model成功缩短结核病治疗使用佐剂host-directed与fda批准的磷酸二酯酶抑制剂治疗小鼠模型.pdfVIP

下载本文档

3
0
约5.72万字
约 8页
2017-09-09 发布于上海
举报

successful shortening of tuberculosis treatment using adjuvant host-directed therapy with fda-approved phosphodiesterase inhibitors in the mouse model成功缩短结核病治疗使用佐剂host-directed与fda批准的磷酸二酯酶抑制剂治疗小鼠模型.pdf

successful shortening of tuberculosis treatment using adjuvant host-directed therapy with fda-approved phosphodiesterase inhibitors in the mouse model成功缩短结核病治疗使用佐剂host-directed与fda批准的磷酸二酯酶抑制剂治疗小鼠模型

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model 1. 1,2. 1 1 1 Mamoudou Maiga , Nisheeth Agarwal , Nicole C. Ammerman , Radhika Gupta , Haidan Guo , 1 1 1,3,4 Marama C. Maiga , Shichun Lun , William R. Bishai

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

successful shortening of tuberculosis treatment using adjuvant host-directed therapy with fda-approved phosphodiesterase inhibitors in the mouse model成功缩短结核病治疗使用佐剂host-directed与fda批准的磷酸二酯酶抑制剂治疗小鼠模型.pdfVIP